作者
Florian Heinen, Kaat Desloovere, A Sebastian Schroeder, Steffen Berweck, Ingo Borggraefe, Anya van Campenhout, Guro L Andersen, Resa Aydin, Jules G Becher, Günther Bernert, Ignacio Martinez Caballero, Lucinda Carr, Emmanuelle Chaleat Valayer, Maria Teresa Desiato, Charlie Fairhurst, Paul Filipetti, Ralph-Ingo Hassink, Ulf Hustedt, Marek Jozwiak, Serdar Ibrahim Kocer, Elisabeth Kolanowski, Ingeborg Krägeloh-Mann, Şehim Kutlay, Helena Mäenpää, Volker Mall, Paul McArthur, Edith Morel, Antigone Papavassiliou, Ignacio Pascual-Pascual, Søren Anker Pedersen, Frank S Plasschaert, Irene van der Ploeg, Olivier Remy-Neris, Anne Renders, Guiseppe Di Rosa, Maja Steinlin, Kristina Tedroff, Joan Vidal Valls, Elke Viehweger, Guy Molenaers
发表日期
2010/1/1
来源
European journal of paediatric neurology
卷号
14
期号
1
页码范围
45-66
出版商
WB Saunders
简介
An interdisciplinary European group of clinical experts in the field of movement disorders and experienced Botulinum toxin users has updated the consensus for the use of Botulinum toxin in the treatment of children with cerebral palsy (CP). A problem-orientated approach was used focussing on both published and practice-based evidence. In part I of the consensus the authors have tabulated the supporting evidence to produce a concise but comprehensive information base, pooling data and experience from 36 institutions in 9 European countries which involves more than 10,000 patients and over 45,000 treatment sessions during a period of more than 280 treatment years. In part II of the consensus the Gross Motor Function Measure (GMFM) and Gross Motor Function Classification System (GMFCS) based Motor Development Curves have been expanded to provide a graphical framework on how to treat the …
引用总数
学术搜索中的文章
F Heinen, K Desloovere, AS Schroeder, S Berweck… - European journal of paediatric neurology, 2010